SEOUL, Jan. 5 (Korea Bizwire) — Daewoong Pharmaceutical Co., a leading South Korean drugmaker, said Thursday that it has signed a contract with Oncorus Inc., a U.S. biotech company, to cooperate in developing and commercializing messenger RNA (mRNA) drugs for cancer patients. Under the deal, the two companies will conduct joint research on the discovery [...]
SEOUL, Oct. 29 (Korea Bizwire) — A U.S. trade panel has invalidated its final ruling that sided with South Korean drugmaker Medytox Inc. against its local rival Daewoong Pharmaceutical Co. over a botulinum toxin strain dispute, company officials here said Friday. In December last year, the U.S. International Trade Commission (ITC) ordered a 21-month ban [...]
SEOUL, Oct. 7 (Korea Bizwire) — A U.S. court accepted a motion to dismiss a patent suit by South Korean drugmaker Medytox Inc. against its local rival Daewoong Pharmaceutical Co. over a botulinum toxin strain, company officials here said Thursday. Medytox had sued Daewoong in the Eastern District Court of Virginia and the Central District [...]
SEOUL, Dec. 21 (Korea Bizwire) — South Korean drugmaker maker Daewoong Pharmaceutical Co. aims to launch a treatment drug for the novel coronavirus early next year, the company’s chief said Monday. Foistar, an oral protease inhibitor, is currently undergoing phase two clinical trial on COVID-19 patients with mild symptoms. The company aims to release the [...]
SEOUL, Dec. 17 (Korea Bizwire) — A U.S. trade panel has upheld its preliminary ruling by siding with South Korean drugmaker Medytox Inc. in a trade dispute, saying its local rival Daewoong Pharmaceutical Co. copied the manufacturing process of a botulinum toxin strain, industry officials here said Thursday. In a final decision, the U.S. International [...]
SEOUL, July 7 (Korea Bizwire) — The U.S. International Trade Commission (ITC) has sided with South Korean drugmaker Medytox Inc. in a trade dispute, saying its local rival Daewoong Pharmaceutical Co. stole secrets on a botulinum toxin strain, industry officials here said Tuesday. In its preliminary verdict, a U.S. trade judge on Monday (U.S. time) [...]
SEOUL, May 20 (Korea Bizwire) — As the ‘war on botox strains’ is escalating between Medytox Inc. and Daewoong Pharmaceutical Co., the tension between the two companies is becoming worse day by day. Medytox has filed a complaint with the U.S. International Trade Commission (USITC), accusing Daewoong of stealing the company’s botox strains. Daewoong has [...]
SEOUL, May 10 (Korea Bizwire) — SK Chemicals Co., a South Korean vaccine maker, said Thursday it has joined with Daewoong Pharmaceutical Co. to sell its herpes zoster vaccine in South Korea. Under the agreement, the two companies will work together on the sales and marketing of Skyzoster, a shingles vaccine developed by SK Chemicals, [...]
SEOUL, Feb. 7 (Korea Bizwire) – Daewoong Pharmaceutical Co., a major South Korean drugmaker, has topped the list in winning approvals from the drug regulatory agency for clinical trials, industry officials said Tuesday. Daewoong Pharmaceutical received approvals from the Ministry of Food and Drug Safety for 16 clinical trials in 2016, compared with seven a [...]
SEOUL, Oct. 14 (Korea Bizwire) – The market for botulinum toxin (BTX), commonly marketed as botox, is rapidly expanding in Korea. But fierce competition between Korean botox distributors has recently intensified, with businesses questioning the safety of each other’s products. There are currently seven BTX distributors globally, three of which are Korean – Medytox, Hugel, [...]